A scientific report has raised questions about how much Leqimbi and Kisunla — the “breakthrough” Alzheimer’s drugs that have hit the market in the last few years — really help slow the disease.
These Alzheimer’s drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated.
